2019
DOI: 10.1038/s41467-019-09118-9
|View full text |Cite|
|
Sign up to set email alerts
|

Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer’s disease model

Abstract: Triggering receptor expressed on myeloid cells 2 (TREM2) is a microglial surface receptor genetically linked to the risk for Alzheimer’s disease (AD). A proteolytic product, soluble TREM2 (sTREM2), is abundant in the cerebrospinal fluid and its levels positively correlate with neuronal injury markers. To gain insights into the pathological roles of sTREM2, we studied sTREM2 in the brain of 5xFAD mice, a model of AD, by direct stereotaxic injection of recombinant sTREM2 protein or by adeno-associated virus (AAV… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

15
234
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 253 publications
(252 citation statements)
references
References 68 publications
15
234
3
Order By: Relevance
“…Additional data will also be required to demonstrate that antibodies with properties similar to 4D9 can be used to modulate microglial function for the treatment of AD or other indications. In that regard, it is currently unclear whether sTREM2 itself may have essential functions in either a cell‐autonomous manner or a non‐cell‐autonomous manner (Ulland et al , ; Zhong et al , , ). Moreover, although a loss of function as caused by certain risk variants of TREM2 disables microglia, relegating them to a homeostatic state (Mazaheri et al , ), absence of progranulin (PGRN) has the opposite consequence, namely arresting microglia in a disease‐associated state (Gotzl et al , ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Additional data will also be required to demonstrate that antibodies with properties similar to 4D9 can be used to modulate microglial function for the treatment of AD or other indications. In that regard, it is currently unclear whether sTREM2 itself may have essential functions in either a cell‐autonomous manner or a non‐cell‐autonomous manner (Ulland et al , ; Zhong et al , , ). Moreover, although a loss of function as caused by certain risk variants of TREM2 disables microglia, relegating them to a homeostatic state (Mazaheri et al , ), absence of progranulin (PGRN) has the opposite consequence, namely arresting microglia in a disease‐associated state (Gotzl et al , ).…”
Section: Discussionmentioning
confidence: 99%
“…Full‐length TREM2, in association with DAP12, forms a heteromeric complex required to activate phospho‐SYK signaling (Colonna, ). Signaling appears to be terminated by α‐secretase‐mediated shedding of the TREM2 ectodomain (Fig A) (Wunderlich et al , ; Kleinberger et al , ), although very recent data suggest that soluble TREM2 (sTREM2) may also have signaling functions (Zhong et al , , ), and requires further investigation. Loss of TREM2‐mediated signaling locks microglia in a homeostatic state and inhibits their transition to disease‐associated microglia (DAM) (Krasemann et al , ; Mazaheri et al , ), which are phenotypically characterized by enhanced migration, chemotaxis, and phagocytosis (Keren‐Shaul et al , ; Mazaheri et al , ).…”
Section: Introductionmentioning
confidence: 99%
“…We suspect that REV‐ERBs activity might participate in LANDO via modulating the expression of receptors in microglia. TREM2 is a well‐characterized Aβ receptor that participates in Aβ endocytosis and elimination and can help glia‐mediated synaptic engulfment in neurodevelopment (Jay et al, ; Zhong et al, ). Interestingly, SR8278 significantly increased the expression of DAP12 which is considered as TREM2 adaptor in microglia, as well as induced TREM2 levels, indicating that SR8278 could propagate TREM2 downstream signaling in microglia.…”
Section: Discussionmentioning
confidence: 99%
“…For example, elevated levels of sTREM2 are associated with cognitive reserve in humans [10], and increasing sTREM2 in a mouse model of AD ameliorates disease pathologies, including reducing amyloid plaque load and improving functional memory [11]. Aside from modulating the function of receptor TREM2, sTREM2 could have independent functions as a cytokine-like signaling molecule [12,13] or function in some other capacities.…”
Section: Introductionmentioning
confidence: 99%